Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence
![Appraising ultra orphan drugs cover page](https://www.ohe.org/wp-content/uploads/2018/03/Appraising-ultra-orphan-drugs-cover-page_0.jpg)
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.